Abstract:One of the major applications of generative models for drug discovery targets the lead-optimization phase. During the optimization of a lead series, it is common to have scaffold constraints imposed on the structure of the molecules designed. Without enforcing such constraints, the probability of generating molecules with the required scaffold is extremely low and hinders the practicality of generative models for de novo drug design. To tackle this issue, we introduce a new algorithm, named SAMOA (Scaffold Constrained Molecular Generation), to perform scaffold-constrained in silico molecular design. We build on the well-known SMILES-based Recurrent Neural Network (RNN) generative model, with a modified sampling procedure to achieve scaffold-constrained generation. We directly benefit from the associated reinforcement learning methods, allowing to design molecules optimized for different properties while exploring only the relevant chemical space. We showcase the method's ability to perform scaffold-constrained generation on various tasks: designing novel molecules around scaffolds extracted from SureChEMBL chemical series, generating novel active molecules on the Dopamine Receptor D2 (DRD2) target, and finally, designing predicted actives on the MMP-12 series, an industrial lead-optimization project.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acs.jcim.0c01015?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acs.jcim.0c01015</a>.Availability of data used to train models and run experiments, algorithmic description of naive policy masking (Algorithm S1), algorithmic description of hill-climbing (Algorithm S2), examples of molecules obtained after sampling the core of fexofenadine (Figure S1 for sampled molecules, Figure S2 for the original molecule), examples of molecules obtained after replacing the ring system of fexofenadine (Figure S3), distributions of ClogP, Molecular Weight, QED and SAS for reference molecules, molecules where a branched decoration was sampled, and molecules where the core was sampled (Figure S4), the 17 validation scaffolds from SureChEMBL (Figure S5), histograms of Tanimoto similarities between generated molecules for each of the DRD2 scaffolds (Figure S6), and unicity of sampled decorations for each open positions of the DRD2 scaffolds (Figure S7) (<a class="ext-link" href="/doi/suppl/10.1021/acs.jcim.0c01015/suppl_file/ci0c01015_si_001.pdf">PDF</a>)This article has not yet been cited by other publications.

3D-SMGE: a pipeline for scaffold-based molecular generation and evaluation

Advances in Deep Learning-Based 3D Molecular Generative Models

A scaffold‐based deep generative model considering molecular stereochemical information

Scaffold-Constrained Molecular Generation

Sc2Mol: a Scaffold-Based Two-Step Molecule Generator with Variational Autoencoder and Transformer.

Structure-Based Drug Design via 3D Molecular Generative Pre-training and Sampling

SMILES-based deep generative scaffold decorator for de-novo drug design

3D-Scaffold: A Deep Learning Framework to Generate 3D Coordinates of Drug-like Molecules with Desired Scaffolds

3DSMILES-GPT: 3D Molecular Pocket-based Generation with Token-only Large Language Model

Synthesis-driven design of 3D molecules for structure-based drug discovery using geometric transformers

Structure-Based de Novo Molecular Generator Combined with Artificial Intelligence and Docking Simulations

Generating 3D Molecular Structures Conditional on a Receptor Binding Site with Deep Generative Models

APMG: 3D Molecule Generation Driven by Atomic Chemical Properties

Deep Generation Model Guided by the Docking Score for Active Molecular Design

DNMG: Deep Molecular Generative Model by Fusion of 3D Information for De Novo Drug Design.

Generation of 3D Molecules in Pockets via Language Model

Scaffold-based molecular design using graph generative model

A Simple Way to Incorporate Target Structural Information in Molecular Generative Models

3D Molecular Pocket-based Generation with Token-only Large Language Model

Learning to Extend Molecular Scaffolds with Structural Motifs

Deep generative model for drug design from protein target sequence